Acepodia
POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER
49 employees · est. 2016 · Alameda, United States
Marker Therapeutics, Inc.
Pioneering a Multi-Antigen Approach
20 employees · est. 2018 · Houston, United States
Acepodia is the older company (2016 vs 2018).
Side-by-Side Comparison
| Metric | Acepodia | Marker Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2018 |
| Headquarters | ||
| Headquarters | Alameda, United States | Houston, United States |
| Employees | ||
| Employees | 49 | 20 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series D | Grant |
| Total Funding | ||
| Total Funding | $256.00M | $98.60M |
| Funding Rounds | ||
| Funding Rounds | 3 | 5 |
| Services | ||
| Services | Not tracked yet | Development of Multi-Antigen Recognizing (MAR) T cell therapies, Clinical trials for novel therapies, Research and development in immunotherapy |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with lymphoma, Individuals with blood cancers, Patients with solid tumors, Healthcare providers, Medical researchers |
| Taxonomy | ||
| Taxonomy | Acepodia, Clinical-stage, Cancer Cell Immunotherapy, Off-the-shelf, NK Cells, Antibody-cell Conjugation, Cell Therapy, Oncology, Immune Effector Cells, Solid Tumors, Hematologic Cancers, Immunotherapeutic Strategies, Interdisciplinary Technology | Immuno-Oncology, T Cell-based Immunotherapies, Hematological Malignancies, Solid Tumor Indications, Multi-antigen Approach, Non-engineered T Cells, Tumor-associated Antigens, Cell Therapy Technology, Cost-effective Manufacturing, Reduced Toxicity, Clinical-stage Company, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Adoptive T Cell Therapy |
| Website | ||
| Website | acepodia.com | markertherapeutics.com |
About Acepodia
Acepodia is a clinical-stage biotechnology company founded in 2016, with a focus on developing innovative and highly effective cell therapies for cancer patients. The company's slogan, "POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER," encapsulates its mission. Acepodia leverages its An...
About Marker Therapeutics, Inc.
Marker Therapeutics, Inc., founded in 2018, is making significant strides in the fields of Biotechnology and Health and Wellness. Headquartered in the United States, the company is driven by the slogan "Pioneering a Multi-Antigen Approach," focusing on the development of advanced T cell-based immuno...
We will tell you when either one moves
BounceWatch watches Acepodia and Marker Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Acepodia and Marker Therapeutics, I... — by email.
Frequently Asked Questions
Compare Acepodia with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Acepodia on 11 Sep 2024, and Marker Therapeutics, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
